Company Filing History:
Years Active: 1996-1997
Title: **Innovative Contributions of Lutz B Giebel in Peptide Synthesis**
Introduction
Lutz B Giebel, an accomplished inventor based in Burlingame, California, has made significant strides in the field of peptide synthesis and biological interactions. With three patents to his name, Giebel's inventions are paving the way for advancements in biotechnology and pharmaceutical research.
Latest Patents
Giebel's most recent patents focus on methods and apparatuses for peptide synthesis and screening. The innovative design involves a special plate featuring a plurality of discreet functionalized substrate areas, arranged in dense arrays ranging from 10x10 to 400x400. These plates are crucial for the rapid preparation of reusable, addressable surface-immobilized arrays of biomolecules, which are used to screen interactions with biologically significant targets. His inventions include the Addressable Synthetic Peptide Combinatorial Library (ASPCL), where hexapeptides can be permanently loaded for research purposes.
Career Highlights
Giebel's career is distinguished by his role at Arris Pharmaceutical Corporation. Here, he has successfully developed pioneering technologies that enhance the efficiency and effectiveness of peptide screening. The innovative multi-slot block assembly he created allows for streamlined preparation of ASPCLs, establishing him as a thought leader in the biotechnology sector.
Collaborations
Throughout his career, Giebel has collaborated with notable colleagues, including Derek Hudson and Charles R Johnson. These partnerships have fostered an environment of innovation and have contributed to the rapid advancement of methodologies in peptide synthesis and biomolecular interactions.
Conclusion
Lutz B Giebel's contributions to the field of peptide synthesis not only showcase his inventive spirit but also highlight the significance of collaboration in scientific advancements. His work at Arris Pharmaceutical Corporation continues to inspire new research opportunities and innovation in the life sciences.